Stay updated on PF-04958242 in Schizophrenia CIAS Clinical Trial
Sign up to get notified when there's something new on the PF-04958242 in Schizophrenia CIAS Clinical Trial page.

Latest updates to the PF-04958242 in Schizophrenia CIAS Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4, a minor maintenance change that does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section consolidated into a single 'Locations' listing the participating states (CA, GA, IL, LA, MD, NJ, TN, TX, WA), replacing individual state subsections. The HHS Vulnerability Disclosure link was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. It appears to be a maintenance change with no modification to the study content, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding status notice at the top of the page has been removed. It previously stated that information may not be up to date during funding lapses and directed users to opm.gov for updates.SummaryDifference0.4%

- Check74 days agoChange DetectedThe study record indicates termination of the trial on Sept 22, 2016 due to internal portfolio prioritization, with a note that this was not due to safety concerns; enrollment and completion details are updated accordingly.SummaryDifference0.3%

- Check103 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

Stay in the know with updates to PF-04958242 in Schizophrenia CIAS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-04958242 in Schizophrenia CIAS Clinical Trial page.